Article
comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
Journal of clinical microbiology - 1 Jun 2005
van Ham Maaike A P C, Bakkers Judith M J E, Harbers Gonneke K, Quint Wim G V, Massuger Leon F A G, Melchers Willem J G
Abstract excerpt
Certain high-risk (HR) human papillomavirus (HPV) types are a necessary cause for the development of cervical disorders. Women with persistent HR HPV infections have an increased risk of developing high-grade cervical lesions, compared with those who have no or low-risk HPV infections. Therefore, implementation of HPV detection into cervical screening programs might identify women at risk of cervical cancer....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
